Drugmaker allegedly conspired with competitors to manipulate drug prices A whistleblower has played a pivotal role in exposing alleged price-fixing by generic drugmaker Glenmark Pharmaceuticals Inc. USA, resulting in a $25 million False Claims Act settlement. Glenmark—the American branch of Glenmark Pharmaceuticals (NSE: Glenmark) based in Mumbai, India—was accused of conspiring with competing generic pharmaceutical […] The post Whistleblower Lawsuit Ends in $25M Price-Fixing Settlement appeared first on Mark A. Strauss Law ..read more

A medical device sales representative who filed the False Claims Act lawsuit received a $1.37 million whistleblower award. Johnson & Johnson (NYSE: JNJ) orthopedics and neurosurgery medical device unit DePuy Synthes has agreed to pay $9.75 million to resolve allegations it violated the False Claims Act by providing illegal kickbacks to an orthopedic surgeon as an incentive for using […] The post Johnson & Johnson Subsidiary Pays $9.75M to Settle Qui Tam Whistleblower Lawsuit over Alleged Kickbacks appeared first on Mark A. Strauss Law ..read more

The fraud was discovered by a medical office manager who filed a whistleblower lawsuit under the qui tam provisions of the False Claims Act. A Georgia ophthalmologist has agreed to pay $1.85 million to settle allegations she violated the False Claims Act by fraudulently billing Medicare for medically unnecessary cataract surgeries and diagnostic tests as well as […] The post Ophthalmologist Pays $1.85M to Settle Allegations She Violated the False Claims Act by Fraudulently Billing Medicare for Unperformed, Medically Unnecessary Procedures appeared first on Mark A. Strauss Law ..read more

The fraud was exposed by two former company executives who filed a qui tam lawsuit under the False Claims Act. They will share a whistleblower award of $8.3 million. Pennsylvania-based cardiac monitoring company BioTelemetry, Inc. (Nasdaq: BEAT) and its subsidiary CardioNet LLC have agreed to pay nearly $45 million to resolve allegations they violated the False Claims Act by knowingly billing federal healthcare programs for services performed by […] The post Cardiac Monitoring Firms Pay $45M to Settle Whistleblower Allegations th ..read more

The settlement follows Cardinal Health’s payment of $13M to resolve related False Claims Act allegations earlier this year A Florida medical group has paid $130,000 to resolve allegations it violated the Anti-Kickback Statute (AKS) and False Claims Act by knowingly taking illegal kickbacks from pharmaceutical distributor Cardinal Health (NYSE: CAH).  The settlement, by the U.S. Department of Justice with Southeast Florida Hematology and Oncology […] The post Florida Medical Group Pays $130K to Settle Allegations it Violated the False Claims Act ..read more

Management pressured staff to inflate Medicare reimbursements by “upcoding” and “ramping.” The Seventh Circuit Court of Appeals has held that arrangements with a third-party litigation funder did not deprive a whistleblower of legal “standing” to pursue her claims under the False Claims Act.  It also upheld a $255 million jury verdict for Medicare fraud against […] The post Appellate Court Approves Whistleblower’s use of Third-Party Litigation Funder, Affirms $255 Million Verdict against Skilled Nursing Facilities for Medicare Fraud appeared first on Mark A. Strauss Law ..read more

A former Genotox billing manager brought the misconduct to the attention of the Justice Department by filing a False Claims Act lawsuit. He received a $1M whistleblower award. Medical-testing firm Genotox Laboratories of Austin, Texas has agreed to pay $5.9 million to resolve allegations it violated the Anti-Kickback Statute and False Claims Act by paying volume-based commissions to independent sales representatives and specimen collectors working in medical practices. According to the U.S. Department of Justice, Genotox paid the sales representatives—whom it referred to as 1099 contractors in ..read more

A medical device sales representative who filed a False Claims Act lawsuit exposing the alleged kickbacks, which were given to a Massachusetts physician, received a $1.37 million whistleblower award. Johnson & Johnson (NYSE: JNJ) orthopedics and neurosurgery medical device unit DePuy Synthes has agreed to pay $9.75 million to resolve allegations it violated the Anti-Kickback Statute and False Claims Act by providing in-kind kickbacks to an orthopedic surgeon as an incentive for using its products. According to the U.S. Department of Justice, the company gave more than $100,000 worth of spi ..read more

The fraud was discovered by a medical office manager who filed a whistleblower lawsuit under the qui tam provisions of the False Claims Act. A Georgia ophthalmologist has agreed to pay $1.85 million to settle allegations she violated the False Claims Act by fraudulently billing Medicare for medically unnecessary cataract surgeries and diagnostic tests as well as medical procedures she never performed. The fraud was exposed by a former medical practice office manager who filed a whistleblower complaint under the qui tam provisions of the False Claims Act. She will receive a whistleblower award ..read more

The fraud was exposed by two former company executives who filed a qui tam lawsuit under the False Claims Act. They will share a whistleblower award of $8.3 million. Pennsylvania-based cardiac monitoring company BioTelemetry, Inc. (Nasdaq: BEAT) and its subsidiary CardioNet LLC have agreed to pay nearly $45 million to resolve allegations they violated the False Claims Act by knowingly billing federal healthcare programs for services performed by cardiovascular technicians located outside the United States in violation of federal law. According to the U.S. Department of Justice, the compa ..read more